Press Resease

Uveitis Treatment Market: by Treatment type (corticosteroids, immunosuppressant, monoclonal antibodies, cycloplegic agents, antibiotics, antivirals, antifungal, and analgesics), Disease type (anterior uveitis, posterior uveitis, intermediate uveitis and panuveitis), Distribution Channel (hospitals, ophthalmology clinics, ambulatory surgical centers, and others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

Published Date: 23-Oct-2019 Category: Healthcare Report Format : PDF Pages: 130 Report Code: ZMR-4904 Status : Published

Description

The report covers forecast and analysis for the Uveitis Treatment market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Uveitis Treatment market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Uveitis Treatment market on a global level. In order to give the users of this report a comprehensive view on the Uveitis Treatment market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein treatment type, disease type, distribution channel, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.

Uveitis is the inflammation of the eye's middle layer called the uvea. It may emerge from causes that are both infectious and non-infectious. The uvea supplies the retina with blood. The retina is the light-sensitive part of the eye that focuses and sends the images to the brain. Because of its blood supply from the uvea, it is usually red. Uveitis is not usually severe. If not treated early, more severe cases may cause vision loss. In one or both eyes, the following symptoms may occur: severe redness in the eye, pain, dark floating spots in your vision, called floaters, light sensitivity and blurred vision. The cause of uveitis is often uncertain and often happens in people who are otherwise well. Sometimes it can be linked with another illness such as an autoimmune disorder or a virus or bacterial infection.

Global Uveitis Treatment Market

The study provides a decisive view on the Uveitis Treatment market by segmenting the market based on treatment type, disease type, distribution channel, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on product, the market is segmented into corticosteroids, immunosuppressant, monoclonal antibodies, cycloplegic agents, antibiotics, antivirals, antifungal, and analgesics. In 2018, corticosteroids dominated the market for anterior uveitis treatment as they are anterior uveitis first-line therapies. They are used as both eye drops and systematic therapy. Corticosteroids are also used in the treatment of continued release, i.e., in implants of the eye. Based on disease type, the market is segmented into anterior uveitis, posterior uveitis, intermediate uveitis and panuveitis. Anterior uveitis led the market space in 2018 due to the high prevalence of adult and youth condition. Increasing work in this field also illustrates the rising age of this type of disease. There is a high risk of loss of vision and cataract, glaucoma, or retinal edema for people with untreated anterior uveitis. Based on distribution channel, the market is segmented into hospitals, ophthalmology clinics, ambulatory surgical centers, and others. Due to the availability of a wide range of options for managing eye inflammation in hospitals, hospital pharmacies led the market in 2018 based on the distribution channel. In addition, hospitals provide a significant number of patients with treatment and care, making hospital pharmacies a leading category. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa with its further bifurcation into major countries such as US, Canada, Germany, UK, France, China, Japan, India, GCC countries, Brazil. Due to the rising prevalence of non-infectious uveitis in the United States, North America led the market in 2018. Additionally, advanced health care facilities and reimbursement policies are attributed to stimulate regional development. Large numbers of drugs are available commercially in the U.S., further boosting the country's demand.

New developments in drug formulations and treatment modalities are continuing, for instance, a major breakthrough was Humira's approval for uveitis care. As a consequence, some of the driving factors are projected to be factors such as rising geriatric population, increasing disease incidence, and new product innovations Redness of the eyes, blurring of the vision, small size of the pupil, and sensitivity to light may be signs of anterior uveitis that may result in permanent blindness if not treated. Increasing occurrence of optical infections coupled with increased knowledge of different treatments is likely to help growth of the market over the forecast period. Some other drivers of the industry are high spending on insurance, increased disposable income, and favorable government regulations.

Key players within global Uveitis Treatment market include Allergan, Inc.; Bausch & Lomb Incorporated; Santen Pharmaceutical Co., Ltd; AbbVie Inc.; Novartis AG; Eyegate Pharmaceuticals, Inc.; Regeneron Pharmaceuticals, Eyepoint pharmaceuticals Inc.; and Alimera Sciences, Inc. amongst others.

The report segments global Uveitis Treatment market as follows:

Global Uveitis Treatment Market: Treatment type Segment Analysis

  • Corticosteroids
  • Immunosuppressant
  • Monoclonal Antibodies
  • Cycloplegic Agents
  • Antibiotics
  • Antivirals
  • Antifungal
  • Analgesics

Global Uveitis Treatment Market: Disease type Segment Analysis

  • Anterior Uveitis
  • Posterior Uveitis
  • Intermediate Uveitis
  • Panuveitis

Global Uveitis Treatment Market: Distribution Channel Segment Analysis

  • Hospitals
  • Ophthalmology Clinics
  • Ambulatory Surgical Centers
  • Others

Global Uveitis Treatment Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Uveitis Treatment Market, 20162025 (USD Million)
    • 2.2. Uveitis Treatment Market: Snapshot
  • Chapter 3. Uveitis Treatment Market Industry Analysis
    • 3.1. Uveitis Treatment Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Driver 1
      • 3.2.2. Driver 2
    • 3.3. Restraints
      • 3.3.1. Restraint 1
      • 3.3.2. Restraint 2
    • 3.4. Opportunity
      • 3.4.1. Government funding and support
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis By Treatment type
      • 3.6.2. Market attractiveness analysis By Disease type
      • 3.6.3. Market attractiveness analysis By Distribution Channel
      • 3.6.4. Market attractiveness analysis by Region
  • Chapter 4. Uveitis Treatment Market Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Uveitis Treatment Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Treatment type launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Uveitis Treatment Market Treatment type Analysis
    • 5.1. Global Uveitis Treatment Market overview: By Treatment type type
      • 5.1.1. Global Uveitis Treatment Market share, By Treatment type,2018 and 2025
    • 5.2. Corticosteroids
      • 5.2.1. Global Uveitis Treatment Market by Treatment Corticosteroids, 20162025 (USD Million)
    • 5.3. Immunosuppressant
      • 5.3.1. Global Uveitis Treatment Market by Treatment Immunosuppressant, 20162025 (USD Million)
    • 5.4. Monoclonal Antibodies
      • 5.4.1. Global Uveitis Treatment Market by Treatment Monoclonal Antibodies, 20162025 (USD Million)
    • 5.5. Cycloplegic Agents
      • 5.5.1. Global Uveitis Treatment Market by Treatment Cycloplegic Agents, 20162025 (USD Million)
    • 5.6. Antibiotics
      • 5.6.1. Global Uveitis Treatment Market by Antibiotics, 20162025 (USD Million)
    • 5.7. Antivirals
      • 5.7.1. Global Uveitis Treatment Market by Antivirals, 20162025 (USD Million)
    • 5.8. Antifungal
      • 5.8.1. Global Uveitis Treatment Market by Antifungal, 20162025 (USD Million)
    • 5.9. Analgesics
      • 5.9.1. Global Uveitis Treatment Market by Analgesics, 20162025 (USD Million)
  • Chapter 6. Global Uveitis Treatment Market Disease type Analysis
    • 6.1. Global Uveitis Treatment Market overview: By Disease type
      • 6.1.1. Global Uveitis Treatment Market share, By Disease type, 2018 and 2025
    • 6.2. Anterior Uveitis
      • 6.2.1. Global Uveitis Treatment Market By Disease Anterior Uveitis, 20162025 (USD Million)
    • 6.3. Posterior Uveitis
      • 6.3.1. Global Uveitis Treatment Market By Disease Posterior Uveitis, 20162025 (USD Million)
    • 6.4. Intermediate Uveitis
      • 6.4.1. Global Uveitis Treatment Market By Disease Intermediate Uveitis, 20162025 (USD Million)
    • 6.5. Panuveitis
      • 6.5.1. Global Uveitis Treatment Market By Disease Panuveitis, 20162025 (USD Million)
  • Chapter 7. Global Uveitis Treatment Market Distribution Channel Analysis
    • 7.1. Global Uveitis Treatment Market overview: By Distribution Channel
      • 7.1.1. Global Uveitis Treatment Market share, By Distribution Channel, 2018 and 2025
    • 7.2. Hospitals
      • 7.2.1. Global Uveitis Treatment Market by Hospitals, 20162025 (USD Million)
    • 7.3. Ophthalmology Clinics
      • 7.3.1. Global Uveitis Treatment Market by Ophthalmology Clinics, 20162025 (USD Million)
    • 7.4. Ambulatory Surgical Centers
      • 7.4.1. Global Uveitis Treatment Market by Ambulatory Surgical Centers, 20162025 (USD Million)
    • 7.5. Others
      • 7.5.1. Global Uveitis Treatment Market by others, 20162025 (USD Million)
  • Chapter 8. Global Uveitis Treatment Market - Regional Analysis
    • 8.1. Global Uveitis Treatment Market overview: by Region
      • 8.1.1. Global Uveitis Treatment Marketshare, by Region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America Uveitis Treatment Market, 20162025 (USD Million)
      • 8.2.2. North America Uveitis Treatment Market revenue, By Treatment type,20162025 (USD Million)
      • 8.2.3. North America Uveitis Treatment Market revenue, By Disease type, 20162025 (USD Million)
      • 8.2.4. North America Uveitis Treatment Market revenue, By Distribution Channel, 20162025 (USD Million)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S.Uveitis Treatment Market revenue, By Treatment type,20162025 (USD Million)
        • 8.2.5.2. The U.S.Uveitis Treatment Market revenue, By Disease type, 20162025 (USD Million)
        • 8.2.5.3. The U.S.Uveitis Treatment Market revenue, By Distribution Channel, 20162025 (USD Million)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America Uveitis Treatment Market revenue, By Treatment type,20162025 (USD Million)
        • 8.2.6.2. Rest of North America Uveitis Treatment Market revenue, By Disease type, 20162025 (USD Million)
        • 8.2.6.3. Rest of North America Uveitis Treatment Market revenue, By Distribution Channel, 20162025 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Uveitis Treatment Market, 20162025 (USD Million)
      • 8.3.2. Europe Uveitis Treatment Market revenue, By Treatment type,20162025 (USD Million)
      • 8.3.3. Europe Uveitis Treatment Market revenue, By Disease type, 20162025 (USD Million)
      • 8.3.4. Europe Uveitis Treatment Market revenue, By Distribution Channel, 20162025 (USD Million)
      • 8.3.5. UK
        • 8.3.5.1. U.K.Uveitis Treatment Market revenue, By Treatment type,20162025 (USD Million)
        • 8.3.5.2. U.K.Uveitis Treatment Market revenue, By Disease type, 20162025 (USD Million)
        • 8.3.5.3. U.K. Uveitis Treatment Market revenue, By Distribution Channel, 20162025 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Uveitis Treatment Market revenue, By Treatment type,20162025 (USD Million)
        • 8.3.6.2. France Uveitis Treatment Market revenue, By Disease type, 20162025 (USD Million)
        • 8.3.6.3. France Uveitis Treatment Market revenue, By Distribution Channel, 20162025 (USD Million)
      • 8.3.7. Germany
        • 8.3.7.1. Germany Uveitis Treatment Market revenue, By Treatment type,20162025 (USD Million)
        • 8.3.7.2. Germany Uveitis Treatment Market revenue, By Disease type, 20162025 (USD Million)
        • 8.3.7.3. Germany Uveitis Treatment Market revenue, By Distribution Channel, 20162025 (USD Million)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of EuropeUveitis Treatment Market revenue, By Treatment type,20162025 (USD Million)
        • 8.3.8.2. Rest of EuropeUveitis Treatment Market revenue, By Disease type, 20162025 (USD Million)
        • 8.3.8.3. Rest of Europe Uveitis Treatment Market revenue, By Distribution Channel, 20162025 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Uveitis Treatment Market, 20162025 (USD Million)
      • 8.4.2. Asia Pacific Uveitis Treatment Market revenue, By Treatment type,20162025 (USD Million)
      • 8.4.3. Asia Pacific Uveitis Treatment Market revenue, By Disease type, 20162025 (USD Million)
      • 8.4.4. Asia Pacific Uveitis Treatment Market revenue, By Distribution Channel, 20162025 (USD Million)
      • 8.4.5. China
        • 8.4.5.1. China Uveitis Treatment Market revenue, By Treatment type,20162025 (USD Million)
        • 8.4.5.2. China Uveitis Treatment Market revenue, By Disease type, 20162025 (USD Million)
        • 8.4.5.3. China Uveitis Treatment Market revenue, By Distribution Channel, 20162025 (USD Million)
      • 8.4.6. Japan
        • 8.4.6.1. Japan Uveitis Treatment Market revenue, By Treatment type,20162025 (USD Million)
        • 8.4.6.2. Japan Uveitis Treatment Market revenue, By Disease type, 20162025 (USD Million)
        • 8.4.6.3. Japan Uveitis Treatment Market revenue, By Distribution Channel, 20162025 (USD Million)
      • 8.4.7. India
        • 8.4.7.1. India Uveitis Treatment Market revenue, By Treatment type,20162025 (USD Million)
        • 8.4.7.2. India Uveitis Treatment Market revenue, By Disease type, 20162025 (USD Million)
        • 8.4.7.3. India Uveitis Treatment Market revenue, By Distribution Channel, 20162025 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Uveitis Treatment Market revenue, By Treatment type,20162025 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific Uveitis Treatment Market revenue, By Disease type, 20162025 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific Uveitis Treatment Market revenue, By Distribution Channel, 20162025 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Uveitis Treatment Market, 20162025 (USD Million)
      • 8.5.2. Latin America Uveitis Treatment Market revenue, By Treatment type,20162025 (USD Million)
      • 8.5.3. Latin America Uveitis Treatment Market revenue, By Disease type, 20162025 (USD Million)
      • 8.5.4. Latin America Uveitis Treatment Market revenue, By Distribution Channel, 20162025 (USD Million)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Uveitis Treatment Market revenue, By Treatment type,20162025 (USD Million)
        • 8.5.5.2. Brazil Uveitis Treatment Market revenue, By Disease type, 20162025 (USD Million)
        • 8.5.5.3. Brazil Uveitis Treatment Market revenue, By Distribution Channel, 20162025 (USD Million)
      • 8.5.6. Rest of LatinAmerica
        • 8.5.6.1. Rest of LatinAmerica Uveitis Treatment Market revenue, By Treatment type,20162025 (USD Million)
        • 8.5.6.2. Rest of LatinAmerica Uveitis Treatment Market revenue, By Disease type, 20162025 (USD Million)
        • 8.5.6.3. Rest of Latin America Uveitis Treatment Market revenue, By Distribution Channel, 20162025 (USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Uveitis Treatment Market, 20162025 (USD Million)
      • 8.6.2. The Middle East and Africa Uveitis Treatment Market revenue, By Treatment type,20162025 (USD Million)
      • 8.6.3. The Middle East and Africa Uveitis Treatment Market revenue, By Disease type, 20162025 (USD Million)
      • 8.6.4. The Middle East and Africa Uveitis Treatment Market revenue, By Distribution Channel, 20162025 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1. Allergan, Inc.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Treatment type Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Bausch & Lomb Incorporated
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Treatment type Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Santen Pharmaceutical Co., Ltd
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Treatment type Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. AbbVie Inc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Treatment type Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Novartis AG
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Treatment type Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Development
    • 9.6. Eyegate Pharmaceuticals, Inc.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Treatment type Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Development
    • 9.7. Regeneron Pharmaceuticals
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Treatment type Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Development
    • 9.8. Eyepoint pharmaceuticals Inc
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Treatment type Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Development
    • 9.9. Alimera Sciences, Inc
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Treatment type Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Development
    • 9.10. Company10
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Treatment type Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Development

Methodology

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com